Search

everythinglearnresearchcommunity

for

Search:↓

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Finasteride 1 mg/day for five years effectively improves hair growth and slows hair loss in men with male pattern baldness, and is safe for long-term use.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

The document concludes that topical minoxidil therapy is safe and effective in promoting hair growth for male pattern baldness.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Low-dose oral minoxidil improves hair growth in male hair loss.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Combining platelet-rich plasma with 5% minoxidil solution improves hair regrowth in androgenetic alopecia patients.

The document concludes that injecting platelet-rich plasma can effectively treat androgenetic alopecia, a type of hair loss.

Dutasteride is safe and effective for treating hair loss, but may decrease libido.

Minoxidil foam effectively promotes hair growth and reduces hair loss in men.

Minoxidil foam 5% effectively treats hair loss in both frontal and vertex scalp regions.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Inflammation and immunity play a key role in androgenetic alopecia, with better treatment outcomes in certain immune-positive cases.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Bald areas have lower cell growth, more DNA damage, and increased cell death.

Testosterone and letrozole treatment speeds up puberty in boys with delayed development.

Apoptosis contributes to hair loss in androgenetic alopecia.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Alopecia causes smaller hair follicles and affects growth-related structures.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

Finasteride use doesn't cause sexual dysfunction in men with hair loss.

PRP therapy works better than minoxidil for treating hair loss.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.